, scientists compared the effect of therapy in leukemia patients with and without Down syndrome.
To account for differences in known risk factors, data from 136 leukemia patients with Down syndrome were matched with those from 407 children who did not have Down syndrome.
Advertisement
Their analysis showed that the levels of leukemia cells decreased equally well in both groups of children after the first month of treatment.
The long-term outcome of children with and without Down syndrome differed. Children with Down syndrome had a worse outcome than children without the disability.
Children with Down syndrome also were more likely to see their leukemia return within five years of treatment. Researchers believe this difference is due to interaction between the genetic changes in Down syndrome.
READ RELATED: Eerie animation shows how the world went from zero to 10 MILLION
Continuing research for treatments with fewer side effects such as targeted therapies and forms of immunotherapy can provide better treatment for children with Down syndrome.
Source: Medindia
Source:
